No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs2839025 |
chr21:47288453-47288454 |
Weak transcription Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs76636709 |
chr21:47288466-47288467 |
Weak transcription Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs549418428 |
chr21:47288469-47288470 |
Weak transcription Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs574118937 |
chr21:47288502-47288503 |
Weak transcription Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs542808162 |
chr21:47288506-47288507 |
Weak transcription Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs567914403 |
chr21:47288543-47288544 |
Weak transcription Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs528806242 |
chr21:47288555-47288556 |
Weak transcription Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs2839026 |
chr21:47288665-47288666 |
Weak transcription Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
9 |
rs113807006 |
chr21:47288671-47288672 |
Weak transcription Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs138656675 |
chr21:47288717-47288718 |
Weak transcription Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs571811459 |
chr21:47288742-47288743 |
Weak transcription Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs190605287 |
chr21:47288772-47288773 |
Weak transcription Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs557004092 |
chr21:47288821-47288822 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs149314420 |
chr21:47288843-47288844 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs568875855 |
chr21:47288863-47288864 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs2183599 |
chr21:47288873-47288874 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
17 |
rs554151595 |
chr21:47288938-47288939 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs368003533 |
chr21:47288973-47288974 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs62211893 |
chr21:47289032-47289033 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs183311964 |
chr21:47289039-47289040 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs371253228 |
chr21:47289040-47289041 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs558450418 |
chr21:47289087-47289088 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs576950982 |
chr21:47289152-47289153 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs113498624 |
chr21:47289311-47289312 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs563773446 |
chr21:47289358-47289359 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs530914430 |
chr21:47289359-47289360 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs543004989 |
chr21:47289369-47289370 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs13050916 |
chr21:47289380-47289381 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
29 |
rs528545518 |
chr21:47289425-47289426 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs547293528 |
chr21:47289453-47289454 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs565475069 |
chr21:47289465-47289466 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs374202747 |
chr21:47289480-47289481 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs34760831 |
chr21:47289484-47289485 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
34 |
rs550916401 |
chr21:47289502-47289503 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs545311492 |
chr21:47289507-47289508 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs2839027 |
chr21:47289543-47289544 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
37 |
rs148514620 |
chr21:47289553-47289554 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs547928304 |
chr21:47289625-47289626 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs142760839 |
chr21:47289637-47289638 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs533573910 |
chr21:47289674-47289675 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs146103595 |
chr21:47289675-47289676 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs2839028 |
chr21:47289683-47289684 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
43 |
rs140054940 |
chr21:47289758-47289759 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs367790400 |
chr21:47289767-47289768 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs556096589 |
chr21:47289788-47289789 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs370051950 |
chr21:47289856-47289857 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs116265077 |
chr21:47289864-47289865 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs4819160 |
chr21:47289870-47289871 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
49 |
rs77283134 |
chr21:47289872-47289873 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs35409950 |
chr21:47289897-47289898 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|